基于CT的栖息地模型预测经动脉化疗栓塞联合分子靶向药物和免疫检查点抑制剂治疗肝细胞癌的肿瘤反应和生存
回顾性纳入200例接受TACE-MTAs-ICIs治疗的不可切除肝细胞癌患者,基于增强CT提取体素级影像组学特征,用K-means聚类识别肿瘤栖息地,构建SVM模型预测肿瘤反应、Cox模型预测总生存。测试队列中栖息地模型预测反应AUC为0.881,OS分层C-index为0.703、1年AUC为0.788、2年AUC为0.806,优于常规影像组学模型;栖息地特征联合临床变量的整合模型AUC为0.884,C-index为0.749、1年AUC为0.831、2年AUC为0.841。
要点
- 栖息地模型预测肿瘤反应AUC为0.881,优于常规影像组学模型。
- 栖息地模型OS分层C-index为0.703,1年AUC为0.788、2年AUC为0.806。
- 栖息地特征联合临床变量后反应AUC为0.884,OS的C-index为0.749。
核心结论
- 基于CT的栖息地模型能更准确、可解释地评估肝细胞癌的治疗反应和总生存,提供反映肿瘤内异质性的无创生物标志物,有望改善个体化治疗规划和临床结局。
研究设计与样本
- 回顾性纳入2019年6月至2024年8月间接受TACE-MTAs-ICIs治疗的200例不可切除肝细胞癌患者,从增强CT提取体素级影像组学特征,用K-means聚类识别肿瘤栖息地,分别从栖息地亚区和全肿瘤体积提取特征,构建SVM模型预测肿瘤反应并作SHAP可解释性分析,同时构建Cox比例风险模型预测OS,并将独立临床危险因素与影像组学特征整合构建联合模型。
诊断标准与关键数值
- 测试队列中栖息地模型预测肿瘤反应AUC为0.881,OS分层C-index为0.703、1年AUC为0.788、2年AUC为0.806。
- 测试队列中栖息地特征联合临床变量的整合模型预测肿瘤反应AUC为0.884,OS的C-index为0.749、1年AUC为0.831、2年AUC为0.841。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: To develop and validate a CT-based habitat model for predicting tumor response and overall survival (OS) in patients with unresectable hepatocellular carcinoma (uHCC) undergoing transarterial chemoembolization, combined with molecular-targeted agents, and immune checkpoint inhibitors (TACE-MTAs-ICIs).
MATERIALS AND METHODS: A total of 200 patients treated with TACE-MTAs-ICIs between June 2019 and August 2024 were retrospectively included. Voxel-level radiomic features were extracted from contrast-enhanced CT images, and tumor habitats were identified using K-means clustering. Radiomic features were extracted from both habitat subregions and the entire tumor volume (conventional radiomics). A support vector machine (SVM) model was developed to predict tumor response, with SHapley Additive exPlanations (SHAP) analysis applied for interpretability. In parallel, a Cox proportional hazards model was constructed to predict OS. Independent clinical risk factors were incorporated with radiomic features to build a combined model. Model performance was evaluated and compared using multiple statistical metrics.
RESULTS: In the test cohort, the habitat model achieved strong performance for tumor response prediction (AUC: 0.881) and OS stratification (C-index: 0.703; 1-year AUC: 0.788; 2-year AUC: 0.806), outperforming the conventional radiomics model. Notably, the integrated model combining habitat features and clinical variables further improved predictive accuracy, yielding an AUC of 0.884 for response prediction and superior OS discrimination (C-index: 0.749; 1-year AUC: 0.831; 2-year AUC: 0.841).
CONCLUSION: The proposed CT-based habitat model enables a more accurate and interpretable assessment of treatment response and OS in HCC, offering valuable noninvasive biomarkers that reflect intra-tumor heterogeneity. This approach holds promise for improving individualized treatment planning and clinical outcomes.
DATA AVAILABILITY STATEMENT: The data that support the findings of this study are available from the corresponding author upon reasonable request.
引用
- Shen X, Zhang JX, Yan HT, et al. CT-Based Habitat Model for Predicting Tumor Response and Survival in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization Combining Molecular Targeted Agents and Immune Checkpoint Inhibitors. Acad Radiol. 2025. PMID: 41058349. doi:10.1016/j.acra.2025.09.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。